shorther study: validating the ajcc prognostic stage in her2 breast cancer
Published 4 years ago • 113 plays • Length 5:01Download video MP4
Download video MP3
Similar videos
-
3:06
prognostic score in early hr /her2- breast cancer: rs, factors, mutations, histology
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
1:25
role of her2 expression and pcr in predicting early outcomes in her2-positive breast cancer
-
1:22
her2dx risk-score in early-stage her2-positive breast cancer
-
0:53
prognostic trials for 21-gene oncotypedx in hr /her2- breast cancer with micrometastases
-
1:52
tils as a prognostic biomarker for treatment de-escalation in her2-positive breast cancer
-
1:14
prognostic value of beta-2 adrenergic receptor levels in her2 breast cancer
-
3:15
identifying her2 breast cancer subgroups associated with prognosis in the altto trial
-
1:42
her2dx and pcr in her2-positive breast cancer: a combined analysis of 4 neoadjuvant studies
-
1:24
treatment de-escalation and escalation strategies in her2-positive breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
2:14
management of premenopausal hr /her2- breast cancer with micro-metastasis
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
2:11
her2 in prognosis of brain metastasis in breast cancer
-
0:54
treatment de-escalation in premenopausal patients with hr /her2- breast cancer and micro-metastasis